what is tyrosine kinase activity?
159680
A tyrosine kinase is an enzyme that can transfer a phosphate group from ATP to the tyrosine residues of specific proteins inside a cell. ... Phosphorylation of proteins by kinases is an important mechanism for communicating signals within a cell (signal transduction) and regulating cellular activity, such as cell division.
1429043
Tyrosine Kinase Inhibitor (TKI) Therapy. Tyrosine kinase inhibitors (TKIs) are a type of targeted therapy. TKIs come as pills, taken orally. A targeted therapy identifies and attacks specific types of cancer cells while causing less damage to normal cells.
1403681
Tyrosine is a nonessential amino acid used to make the catecholamine neurotransmitters dopamine (DA), norepinephrine (NE), and epinephrine (E). N-Acetyl Tyrosine (NAT) is the amino acid tyrosine bonded to an acetyl group. The acetyl group must be removed from NAT to form tyrosine and become active in the body.
1307139
The G-protein is said to be in its active state, ready to interact with effectors. After some time, in the order of milliseconds to tens of seconds, a GTPase-activating protein catalyzes the hydrolysis of GTP into GDP and Pi and the G-protein returns to its GDP-bound inactive state.
776200
Creatine kinase (CK), also known as creatine phosphokinase (CPK) or phosphocreatine kinase, is an enzyme (EC 2.7. 3.2) expressed by various tissues and cell types.
1212671
Tyrosinase activity is very important. If uncontrolled during the synthesis of melanin, it results in increased melanin synthesis. Decreasing tyrosinase activity has been targeted for the betterment or prevention of conditions related to the hyperpigmentation of the skin, such as melasma and age spots.
554802
Through phosphorylation, Cdks signal the cell that it is ready to pass into the next stage of the cell cycle. As their name suggests, Cyclin-Dependent Protein Kinases are dependent on cyclins, another class of regulatory proteins. Cyclins bind to Cdks, activating the Cdks to phosphorylate other molecules.
1303470
Background. The epidermal growth factor receptor (EGFR) belongs to a family of receptor tyrosine kinases that includes three other members (erbB2/HER-2, erbB3/HER-3, and erbB4/HER-4).
1028967
CHEMISTRY GLOSSARY Tyrosine is hydrophobic amino acids with aromatic side chain. Tyrosine is large aromatic residue that is normally found buried in the interior of a protein and is important for protein stability.
926309
MAPK can phosphorylate C-myc. MAPK phosphorylates and activates MNK, which, in turn, phosphorylates CREB. MAPK also regulates the transcription of the C-Fos gene. By altering the levels and activities of transcription factors, MAPK leads to altered transcription of genes that are important for the cell cycle.
631963
Protein kinase C (PKC), a Ca2+-and phospholipid-dependent protein kinase, is now known to be regulated by sn-1,2-diacylglycerol (DAG) second messengers and is the intracellular phorbol ester receptor.
400060
AMP-activated protein kinase (AMPK) is a phylogenetically conserved fuel-sensing enzyme that is present in all mammalian cells. During exercise, it is activated in skeletal muscle in humans, and at least in rodents, also in adipose tissue, liver and perhaps other organs by events that increase the AMP/ATP ratio.
1330302
Role in the cell cycle. During G1 and S phase, the CDK1 subunit of MPF is inactive due to an inhibitory enzyme, Wee1. Wee1 phosphorylates the Tyr-15 residues in yeast and Tyr-15 residues in humans of CDK1, rendering MPF inactive.
148210
One type of genetically-driven cancer is called tropomyosin receptor kinase (TRK) fusion cancer. Neurotrophic tyrosine receptor kinase (NTRK) genes provide instructions for TRK proteins. When an NTRK gene joins or “fuses” with an unrelated gene, it starts to produce an altered TRK fusion protein.
520842
5.6 Janus kinases JAKs correspond to a family of protein tyrosine kinases that interact with cytokine receptors and are activated by transphosphorylation in response to ligand–receptor interaction.
296753
The BRAF protein is a serine/threonine-kinase involved in the mitogen-activated protein-kinase (MAPK) signaling pathway (B-Raf/Mek/Erk proteins).
635153
The standard treatment for chronic phase CML is a tyrosine kinase inhibitor (TKI) like imatinib (Gleevec), nilotinib (Tasigna), dasatinib (Sprycel), or bosutinib (Bosulif). If the first drug stops working or it never really worked well at all, the dose may be increased or another TKI might be tried.